-
1
-
-
52649083791
-
Epoetin alfa and darbepoetin alfa: Effects on ventricular hypertrophy in patients with chronic kidney disease
-
Chen HH, Tarng DC, Lee KF, Wu CY, Chen YC (2008) Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease. J Nephrol 21: 543-549.
-
(2008)
J Nephrol
, vol.21
, pp. 543-549
-
-
Chen, H.H.1
Tarng, D.C.2
Lee, K.F.3
Wu, C.Y.4
Chen, Y.C.5
-
3
-
-
33645470185
-
Update on erythropoietin treatment: Should hemoglobin be normalized in patients with chronic kidney disease?
-
Paoletti E, Cannella G (2006) Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease? J Am Soc Nephrol 17: S74-77.
-
(2006)
J Am Soc Nephrol
, vol.17
-
-
Paoletti, E.1
Cannella, G.2
-
4
-
-
33845641241
-
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
-
Rev. CD003967
-
Strippoli GF, Navaneethan SD, Craig JC (2006) Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. CD003967.
-
(2006)
Cochrane Database Syst
-
-
Strippoli, G.F.1
Navaneethan, S.D.2
Craig, J.C.3
-
5
-
-
44649160130
-
From anemia trials to clinical practice: Understanding the risks and benefits when setting goals for therapy
-
Coyne DW (2008) From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy. Semin Dial 21: 212-216.
-
(2008)
Semin Dial
, vol.21
, pp. 212-216
-
-
Coyne, D.W.1
-
6
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
-
Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084.
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
Eckardt, K.U.4
Macdougall, I.C.5
-
7
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease
-
Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098.
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
Barnhart, H.4
Sapp, S.5
-
8
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, et al. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590.
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
Egrie, J.C.4
Nissenson, A.R.5
-
10
-
-
0036315869
-
Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress
-
Stenvinkel P, Barany P (2002) Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 17 Suppl 5: 32-37.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.SUPPL. 5
, pp. 32-37
-
-
Stenvinkel, P.1
Barany, P.2
-
11
-
-
33746265282
-
Erythropoietin resistance in the treatment of the anemia of chronic renal failure
-
Priyadarshi A, Shapiro JI (2006) Erythropoietin resistance in the treatment of the anemia of chronic renal failure. Semin Dial 19: 273-278.
-
(2006)
Semin Dial
, vol.19
, pp. 273-278
-
-
Priyadarshi, A.1
Shapiro, J.I.2
-
12
-
-
33947192111
-
Erythropoietin and iron-restricted erythropoiesis
-
Goodnough LT (2007) Erythropoietin and iron-restricted erythropoiesis. Exp Hematol 35: 167-172.
-
(2007)
Exp Hematol
, vol.35
, pp. 167-172
-
-
Goodnough, L.T.1
-
13
-
-
44349147141
-
Serum prohepcidin as an indicator of iron status in dialysis patients
-
Tsuchihashi D, Abe T, Komaba H, Fujii H, Hamada Y, et al. (2008) Serum prohepcidin as an indicator of iron status in dialysis patients. Ther Apher Dial 12: 226-231.
-
(2008)
Ther Apher Dial
, vol.12
, pp. 226-231
-
-
Tsuchihashi, D.1
Abe, T.2
Komaba, H.3
Fujii, H.4
Hamada, Y.5
-
14
-
-
36249027662
-
Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients
-
Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, et al. (2008) Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol 28: 115-121.
-
(2008)
Am J Nephrol
, vol.28
, pp. 115-121
-
-
Kato, A.1
Tsuji, T.2
Luo, J.3
Sakao, Y.4
Yasuda, H.5
-
15
-
-
33751258923
-
Does hepcidin affect erythropoiesis in hemodialysis patients?
-
Eleftheriadis T, Kartsios C, Liakopoulos V, Antoniadi G, Ditsa M, et al. (2006) Does hepcidin affect erythropoiesis in hemodialysis patients? Acta Haematol 116: 238-244.
-
(2006)
Acta Haematol
, vol.116
, pp. 238-244
-
-
Eleftheriadis, T.1
Kartsios, C.2
Liakopoulos, V.3
Antoniadi, G.4
Ditsa, M.5
-
16
-
-
0035990783
-
Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients
-
Tarng DC, Huang TP (2002) Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients. Nephrol Dial Transplant 17: 1063-1069.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 1063-1069
-
-
Tarng, D.C.1
Huang, T.P.2
-
17
-
-
0030846076
-
Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure
-
Ahluwalia N, Skikne BS, Savin V, Chonko A (1997) Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis 30: 532-541.
-
(1997)
Am J Kidney Dis
, vol.30
, pp. 532-541
-
-
Ahluwalia, N.1
Skikne, B.S.2
Savin, V.3
Chonko, A.4
-
18
-
-
0032871954
-
Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients
-
Daschner M, Mehls O, Schaefer F (1999) Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients. Clin Nephrol 52: 246-252.
-
(1999)
Clin Nephrol
, vol.52
, pp. 246-252
-
-
Daschner, M.1
Mehls, O.2
Schaefer, F.3
-
19
-
-
0036847340
-
Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients
-
Chiang WC, Tsai TJ, Chen YM, Lin SL, Hsieh BS (2002) Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. Clin Nephrol 58: 363-369.
-
(2002)
Clin Nephrol
, vol.58
, pp. 363-369
-
-
Chiang, W.C.1
Tsai, T.J.2
Chen, Y.M.3
Lin, S.L.4
Hsieh, B.S.5
-
20
-
-
0025328797
-
The gene for the human erythropoietin receptor: Analysis of the coding sequence and assignment to chromosome 19p
-
Winkelmann JC, Penny LA, Deaven LL, Forget BG, Jenkins RB (1990) The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p. Blood 76: 24-30.
-
(1990)
Blood
, vol.76
, pp. 24-30
-
-
Winkelmann, J.C.1
Penny, L.A.2
Deaven, L.L.3
Forget, B.G.4
Jenkins, R.B.5
-
21
-
-
0025337049
-
Human erythropoietin receptor: Cloning, expression, and biologic characterization
-
Jones SS, D'Andrea AD, Haines LL, Wong GG (1990) Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood 76: 31-35.
-
(1990)
Blood
, vol.76
, pp. 31-35
-
-
Jones, S.S.1
D'Andrea, A.D.2
Haines, L.L.3
Wong, G.G.4
-
22
-
-
20844450249
-
Erythropoietin receptors: Their role beyond erythropoiesis
-
Rossert J, Eckardt KU (2005) Erythropoietin receptors: their role beyond erythropoiesis. Nephrol Dial Transplant 20: 1025-1028.
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 1025-1028
-
-
Rossert, J.1
Eckardt, K.U.2
-
23
-
-
0028017559
-
Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow
-
Barron C, Migliaccio AR, Migliaccio G, Jiang Y, Adamson JW, et al. (1994) Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene 147: 263-268.
-
(1994)
Gene
, vol.147
, pp. 263-268
-
-
Barron, C.1
Migliaccio, A.R.2
Migliaccio, G.3
Jiang, Y.4
Adamson, J.W.5
-
24
-
-
0025942082
-
Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin
-
Todokoro K, Kuramochi S, Nagasawa T, Abe T, Ikawa Y (1991) Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin. Gene 106: 283-284.
-
(1991)
Gene
, vol.106
, pp. 283-284
-
-
Todokoro, K.1
Kuramochi, S.2
Nagasawa, T.3
Abe, T.4
Ikawa, Y.5
-
25
-
-
0027436101
-
Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody
-
Baynes RD, Reddy GK, Shih YJ, Skikne BS, Cook JD (1993) Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody. Blood 82: 2088-2095.
-
(1993)
Blood
, vol.82
, pp. 2088-2095
-
-
Baynes, R.D.1
Reddy, G.K.2
Shih, Y.J.3
Skikne, B.S.4
Cook, J.D.5
-
26
-
-
0036019540
-
Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples
-
Westphal G, Braun K, Debus J (2002) Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples. Clin Exp Med 2: 45-52.
-
(2002)
Clin Exp Med
, vol.2
, pp. 45-52
-
-
Westphal, G.1
Braun, K.2
Debus, J.3
-
27
-
-
0029914394
-
Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma
-
Harris KW, Winkelmann JC (1996) Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma. Am J Hematol 52: 8-13.
-
(1996)
Am J Hematol
, vol.52
, pp. 8-13
-
-
Harris, K.W.1
Winkelmann, J.C.2
-
28
-
-
0029976868
-
Lack of relationship between soluble erythropoietin receptor levels and erythroid parameters in anemic patients
-
Yoshida S, Bessho M, Sakate K, Hirasawa I, Murayoshi M, et al. (1996) Lack of relationship between soluble erythropoietin receptor levels and erythroid parameters in anemic patients. Blood 88: 3246-3247.
-
(1996)
Blood
, vol.88
, pp. 3246-3247
-
-
Yoshida, S.1
Bessho, M.2
Sakate, K.3
Hirasawa, I.4
Murayoshi, M.5
-
29
-
-
0037767746
-
Expression of erythropoietin receptor splice variants in human cancer
-
Arcasoy MO, Jiang X, Haroon ZA (2003) Expression of erythropoietin receptor splice variants in human cancer. Biochem Biophys Res Commun 307: 999-1007.
-
(2003)
Biochem Biophys Res Commun
, vol.307
, pp. 999-1007
-
-
Arcasoy, M.O.1
Jiang, X.2
Haroon, Z.A.3
-
30
-
-
34547851589
-
Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia
-
Soliz J, Gassmann M, Joseph V (2007) Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia. J Physiol 583: 329-336.
-
(2007)
J Physiol
, vol.583
, pp. 329-336
-
-
Soliz, J.1
Gassmann, M.2
Joseph, V.3
-
31
-
-
0027481011
-
Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus
-
Ferro FE Jr, Kozak SL, Hoatlin ME, Kabat D (1993) Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem 268: 5741-5747.
-
(1993)
J Biol Chem
, vol.268
, pp. 5741-5747
-
-
Ferro Jr, F.E.1
Kozak, S.L.2
Hoatlin, M.E.3
Kabat, D.4
-
32
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
-
Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
-
(2003)
J Clin Invest
, vol.111
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.Y.2
Merchan, J.3
Lim, K.H.4
Li, J.5
-
33
-
-
33744985816
-
Soluble endoglin contributes to the pathogenesis of preeclampsia
-
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649.
-
(2006)
Nat Med
, vol.12
, pp. 642-649
-
-
Venkatesha, S.1
Toporsian, M.2
Lam, C.3
Hanai, J.4
Mammoto, T.5
-
34
-
-
0027281793
-
The extracytoplasmic domain of the erythropoietin receptor forms a monomeric complex with erythropoietin
-
Yet MG, Jones SS (1993) The extracytoplasmic domain of the erythropoietin receptor forms a monomeric complex with erythropoietin. Blood 82: 1713-1719.
-
(1993)
Blood
, vol.82
, pp. 1713-1719
-
-
Yet, M.G.1
Jones, S.S.2
-
35
-
-
3042794598
-
Erythropoietin regulation of Raf-1 and MEK: Evidence for a Ras-independent mechanism
-
Chen C, Sytkowski AJ (2004) Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Blood 104: 73-80.
-
(2004)
Blood
, vol.104
, pp. 73-80
-
-
Chen, C.1
Sytkowski, A.J.2
-
36
-
-
0035914336
-
Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc
-
Chen C, Sytkowski AJ (2001) Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J Biol Chem 276: 38518-38526.
-
(2001)
J Biol Chem
, vol.276
, pp. 38518-38526
-
-
Chen, C.1
Sytkowski, A.J.2
-
37
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592.
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
Rauh-Hain, J.A.4
Tamez, H.5
-
38
-
-
65649103459
-
Plasma gelsolin and circulating actin correlate with hemodialysis mortality
-
Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, et al. (2009) Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 20: 1140-1148.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1140-1148
-
-
Lee, P.S.1
Sampath, K.2
Karumanchi, S.A.3
Tamez, H.4
Bhan, I.5
-
39
-
-
34948869354
-
Vitamin D levels and early mortality among incident hemodialysis patients
-
Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, et al. (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013.
-
(2007)
Kidney Int
, vol.72
, pp. 1004-1013
-
-
Wolf, M.1
Shah, A.2
Gutierrez, O.3
Ankers, E.4
Monroy, M.5
-
40
-
-
48149102507
-
Impact of activated vitamin D and race on survival among hemodialysis patients
-
Wolf M, Betancourt J, Chang Y, Shah A, Teng M, et al. (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19: 1379-1388.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1379-1388
-
-
Wolf, M.1
Betancourt, J.2
Chang, Y.3
Shah, A.4
Teng, M.5
-
41
-
-
58149352646
-
Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients
-
Brunelli SM, Lynch KE, Ankers ED, Joffe MM, Yang W, et al. (2008) Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients. Clin J Am Soc Nephrol 3: 1733-1740.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1733-1740
-
-
Brunelli, S.M.1
Lynch, K.E.2
Ankers, E.D.3
Joffe, M.M.4
Yang, W.5
-
42
-
-
60149091852
-
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients
-
Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, et al. (2009) Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 53: 823-834.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 823-834
-
-
Kalantar-Zadeh, K.1
Lee, G.H.2
Miller, J.E.3
Streja, E.4
Jing, J.5
-
44
-
-
56049125423
-
The association of race with erythropoietin dose in patients on long-term hemodialysis
-
Lacson E Jr, Rogus J, Teng M, Lazarus JM, Hakim RM (2008) The association of race with erythropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis 52: 1104-1114.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 1104-1114
-
-
Lacson Jr, E.1
Rogus, J.2
Teng, M.3
Lazarus, J.M.4
Hakim, R.M.5
-
45
-
-
3042725549
-
Derivatives of erythropoietin that are tissue protective but not erythropoietic
-
Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242.
-
(2004)
Science
, vol.305
, pp. 239-242
-
-
Leist, M.1
Ghezzi, P.2
Grasso, G.3
Bianchi, R.4
Villa, P.5
-
46
-
-
0029998539
-
Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit
-
Krosl J, Damen JE, Krystal G, Humphries RK (1996) Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit. J Biol Chem 271: 27432-27437.
-
(1996)
J Biol Chem
, vol.271
, pp. 27432-27437
-
-
Krosl, J.1
Damen, J.E.2
Krystal, G.3
Humphries, R.K.4
-
47
-
-
50849121381
-
Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease
-
Keithi-Reddy SR, Addabbo F, Patel TV, Mittal BV, Goligorsky MS, et al. (2008) Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int 74: 782-790.
-
(2008)
Kidney Int
, vol.74
, pp. 782-790
-
-
Keithi-Reddy, S.R.1
Addabbo, F.2
Patel, T.V.3
Mittal, B.V.4
Goligorsky, M.S.5
-
48
-
-
0016640079
-
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
-
Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 321-334.
-
(1975)
Blood
, vol.45
, pp. 321-334
-
-
Lozzio, C.B.1
Lozzio, B.B.2
-
49
-
-
0035887309
-
Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase
-
Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, et al. (2001) Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J 20: 5666-5677.
-
(2001)
EMBO J
, vol.20
, pp. 5666-5677
-
-
Kubota, Y.1
Tanaka, T.2
Kitanaka, A.3
Ohnishi, H.4
Okutani, Y.5
-
50
-
-
0034007818
-
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
-
Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, et al. (2000) Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 80: 443-454.
-
(2000)
Lab Invest
, vol.80
, pp. 443-454
-
-
Hornig, C.1
Barleon, B.2
Ahmad, S.3
Vuorela, P.4
Ahmed, A.5
-
51
-
-
0025241907
-
Factor analysis of in vitro antitumor activities of platinum complexes
-
Kuramochi H, Motegi A, Maruyama S, Okamoto K, Takahashi K, et al. (1990) Factor analysis of in vitro antitumor activities of platinum complexes. Chem Pharm Bull (Tokyo) 38: 123-127.
-
(1990)
Chem Pharm Bull (Tokyo)
, vol.38
, pp. 123-127
-
-
Kuramochi, H.1
Motegi, A.2
Maruyama, S.3
Okamoto, K.4
Takahashi, K.5
-
52
-
-
4644317542
-
Postsecretion neutralization of transgene-derived effect: Soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle
-
Maruyama H, Higuchi M, Higuchi N, Kameda S, Saito M, et al. (2004) Postsecretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle. J Gene Med 6: 228-237.
-
(2004)
J Gene Med
, vol.6
, pp. 228-237
-
-
Maruyama, H.1
Higuchi, M.2
Higuchi, N.3
Kameda, S.4
Saito, M.5
-
53
-
-
0026442116
-
Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor
-
Nagao M, Masuda S, Abe S, Ueda M, Sasaki R (1992) Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor. Biochem Biophys Res Commun 188: 888-897.
-
(1992)
Biochem Biophys Res Commun
, vol.188
, pp. 888-897
-
-
Nagao, M.1
Masuda, S.2
Abe, S.3
Ueda, M.4
Sasaki, R.5
-
54
-
-
11244333356
-
New avenues of exploration for erythropoietin
-
Maiese K, Li F, Chong ZZ (2005) New avenues of exploration for erythropoietin. JAMA 293: 90-95.
-
(2005)
JAMA
, vol.293
, pp. 90-95
-
-
Maiese, K.1
Li, F.2
Chong, Z.Z.3
-
55
-
-
54049113367
-
Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation
-
Buck I, Morceau F, Cristofanon S, Heintz C, Chateauvieux S, et al. (2008) Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Biochem Pharmacol 76: 1229-1239.
-
(2008)
Biochem Pharmacol
, vol.76
, pp. 1229-1239
-
-
Buck, I.1
Morceau, F.2
Cristofanon, S.3
Heintz, C.4
Chateauvieux, S.5
-
56
-
-
36348966705
-
Cellular protection by erythropoietin: New therapeutic implications?
-
Joyeux-Faure M (2007) Cellular protection by erythropoietin: new therapeutic implications? J Pharmacol Exp Ther 323: 759-762.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 759-762
-
-
Joyeux-Faure, M.1
-
57
-
-
4644310308
-
Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
-
Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, et al. (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104: 2073-2080.
-
(2004)
Blood
, vol.104
, pp. 2073-2080
-
-
Beleslin-Cokic, B.B.1
Cokic, V.P.2
Yu, X.3
Weksler, B.B.4
Schechter, A.N.5
-
58
-
-
0027620152
-
Endocytosis of growth factor receptors
-
Sorkin A, Waters CM (1993) Endocytosis of growth factor receptors. Bioessays 15: 375-382.
-
(1993)
Bioessays
, vol.15
, pp. 375-382
-
-
Sorkin, A.1
Waters, C.M.2
-
59
-
-
0030030714
-
Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms
-
Neumann D, Yuk MH, Lodish HF, Lederkremer GZ (1996) Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms. Biochem J 313 (Pt 2): 391-399.
-
(1996)
Biochem J
, vol.313
, Issue.PART 2
, pp. 391-399
-
-
Neumann, D.1
Yuk, M.H.2
Lodish, H.F.3
Lederkremer, G.Z.4
-
60
-
-
7444256054
-
Epoetin requirements predict mortality in hemodialysis patients
-
Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ (2004) Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 44: 866-876.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 866-876
-
-
Zhang, Y.1
Thamer, M.2
Stefanik, K.3
Kaufman, J.4
Cotter, D.J.5
-
61
-
-
0036408985
-
Non-erythropoietin-based anaemia management in chronic kidney disease
-
Horl WH (2002) Non-erythropoietin-based anaemia management in chronic kidney disease. Nephrol Dial Transplant 17 Suppl 11: 35-38.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.SUPPL. 11
, pp. 35-38
-
-
Horl, W.H.1
-
62
-
-
0142231519
-
Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance
-
Greenwood RN, Ronco C, Gastaldon F, Brendolan A, Homel P, et al. (2003) Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance. Kidney Int Suppl. S78-86.
-
(2003)
Kidney Int Suppl
-
-
Greenwood, R.N.1
Ronco, C.2
Gastaldon, F.3
Brendolan, A.4
Homel, P.5
-
63
-
-
3042772186
-
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
-
Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, et al. (2004) Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44: 94-111.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 94-111
-
-
Pisoni, R.L.1
Bragg-Gresham, J.L.2
Young, E.W.3
Akizawa, T.4
Asano, Y.5
-
64
-
-
40349103260
-
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
-
Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, et al. (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299: 914-924.
-
(2008)
JAMA
, vol.299
, pp. 914-924
-
-
Bennett, C.L.1
Silver, S.M.2
Djulbegovic, B.3
Samaras, A.T.4
Blau, C.A.5
-
65
-
-
14744278436
-
Anemia of chronic disease
-
Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
-
(2005)
N Engl J Med
, vol.352
, pp. 1011-1023
-
-
Weiss, G.1
Goodnough, L.T.2
|